Cutaneous tumors with melanocytic differentiation represent a broad group of neoplasms of both melanocytic and non-melanocytic origin. Besides traditional members such as clear-cell sarcoma (CCS) and PEComa, the latter group has recently expanded to also include MITF::CREM fusion-associated tumors, but the available data are limited. Herein, we present a third case of this rare neoplasm which occurred in the temporal region in a 1-year-old girl. It was an infiltratively growing polypoid dermal-based lesion lacking an intraepidermal component. It consisted of cellular solid sheets or small nests of epithelioid to spindled cells with a predominantly eosinophilic and much less commonly clear cytoplasm. The nuclei had round to ovoid shape and exhibited moderate to high-grade atypia and prominent nucleoli. The mitotic activity was 11 mitoses per 10 high-power fields, and atypical mitotic figures were present. Immunohistochemically, the tumor was strongly positive with S100 protein, SOX10, and MITF, while HMB45, tyrosinase, and Melan A were negative. Extensive molecular analysis revealed only MITF::CREM gene fusion. There had no evidence of disease 9 months after the diagnosis. These tumors need to be distinguished from malignant tumors with melanocytic differentiation, primarily from melanoma. However, additional cases still need to be studied to precisely define their biological potential and establish their nosologic status.

Bioptical Laboratory Ltd Plzen Czech Republic

Department of Pathology Faculty of Medicine in Plzen Charles University Plzen Czech Republic

Department of Pediatric Hematology and Oncology National Institute of Children's Diseases and Medical Faculty Comenius University Bratislava Slovakia

Medical Laboratory CSD Health Care Ltd Kyiv Ukraine

See more in PubMed

Cellier L, Perron E, Pissaloux D et al (2018) Cutaneous melanocytoma with CRTC1-TRIM11 fusion: report of 5 cases resembling clear cell sarcoma. Am J Surg Pathol 42:382–391 PubMed DOI

Hanna J, Ko JS, Billings SD et al (2022) Cutaneous melanocytic tumor with CRTC1::TRIM11 translocation : an emerging entity analyzed in a series of 41 cases. Am J Surg Pathol 46:1457–1466 PubMed DOI

de la Fouchardiere A, Pissaloux D, Tirode F et al (2021) Clear cell tumor with melanocytic differentiation and ACTIN-MITF translocation: report of 7 cases of a novel entity. Am J Surg Pathol 45:962–968 PubMed DOI

de la Fouchardiere A, Pissaloux D, Tirode F et al (2021) Clear cell tumor with melanocytic differentiation and MITF-CREM translocation: a novel entity similar to clear cell sarcoma. Virchows Arch 479:841–846 PubMed DOI

Alexandrescu S, Imamovic-Tuco A, Janeway K et al (2023) Clear cell tumor with melanocytic differentiation and MITF::CREM translocation. J Cutan Pathol 50:619–622 PubMed DOI

Gerami P, Li G, Pouryazdanparast P et al (2012) A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms. Am J Surg Pathol 36:808–817 PubMed DOI

Donati M, Nosek D, Waldenback P et al (2021) MAP2K1-mutated melanocytic neoplasms with a SPARK-like morphology. Am J Dermatopathol 43:412–417 PubMed DOI

Warmke LM, Michal M, Martinek P et al (2023) "PRRX1-rearranged mesenchymal tumors": expanding the immunohistochemical profile and molecular spectrum of a recently described entity with the proposed revision of nomenclature. Virchows Arch

Fischer GM, Papke DJ Jr (2023) Gene fusions in superficial mesenchymal neoplasms: emerging entities and useful diagnostic adjuncts. Semin Diagn Pathol 40(4):246–257 PubMed DOI

Bertolotto C, Abbe P, Hemesath TJ et al (1998) Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J Cell Biol 142:827–835 PubMed DOI PMC

Price ER, Fisher DE (2001) Sensorineural deafness and pigmentation genes: melanocytes and the Mitf transcriptional network. Neuron 30:15–18 PubMed DOI

Kazakov DV, Michal M (2007) Melanocytic "ball-in-mitts" and "microalveolar structures" and their role in the development of cellular blue nevi. Ann Diagn Pathol 11:160–175 PubMed DOI

Barnhill RL, Cerroni L, Cook M et al (2010) State of the art, nomenclature, and points of consensus and controversy concerning benign melanocytic lesions: outcome of an international workshop. Adv Anat Pathol 17:73–90 PubMed DOI

Wiesner T, He J, Yelensky R et al (2014) Kinase fusions are frequent in Spitz tumours and spitzoid melanomas. Nat Commun 5:3116 PubMed DOI

Wu G, Barnhill RL, Lee S et al (2016) The landscape of fusion transcripts in spitzoid melanoma and biologically indeterminate spitzoid tumors by RNA sequencing. Mod Pathol 29:359–369 PubMed DOI PMC

Hagstrom M, Fumero-Velazquez M, Dhillon S et al (2023) An update on genomic aberrations in Spitz naevi and tumours. Pathology. 55:196–205 PubMed DOI

Update on cutaneous mesenchymal tumors in the 5th edition of WHO classification of skin tumors with an emphasis on new fusion-associated neoplasms